Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alkynes | 3 | 2014 | 7 | 1.250 |
Why?
|
| Silanes | 2 | 2014 | 4 | 0.730 |
Why?
|
| Siloxanes | 2 | 2011 | 3 | 0.640 |
Why?
|
| Palladium | 2 | 2011 | 9 | 0.640 |
Why?
|
| Amides | 1 | 2014 | 18 | 0.480 |
Why?
|
| Titanium | 1 | 2014 | 34 | 0.470 |
Why?
|
| Iridium | 1 | 2014 | 1 | 0.470 |
Why?
|
| Alkenes | 1 | 2014 | 15 | 0.460 |
Why?
|
| Catalysis | 5 | 2014 | 133 | 0.460 |
Why?
|
| Molecular Structure | 5 | 2014 | 239 | 0.440 |
Why?
|
| Neutral Ceramidase | 2 | 2023 | 3 | 0.410 |
Why?
|
| Stereoisomerism | 4 | 2014 | 45 | 0.410 |
Why?
|
| Casein Kinase Idelta | 3 | 2015 | 3 | 0.360 |
Why?
|
| Carbon | 1 | 2011 | 93 | 0.350 |
Why?
|
| Oxygen | 1 | 2011 | 217 | 0.340 |
Why?
|
| Organosilicon Compounds | 1 | 2008 | 1 | 0.310 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 40 | 0.300 |
Why?
|
| Zinc | 1 | 2008 | 52 | 0.300 |
Why?
|
| Nanoparticles | 1 | 2011 | 273 | 0.280 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2005 | 9 | 0.260 |
Why?
|
| Nitro Compounds | 1 | 2005 | 10 | 0.260 |
Why?
|
| Hydrocarbons | 1 | 2005 | 41 | 0.260 |
Why?
|
| Ceramides | 1 | 2023 | 22 | 0.220 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2014 | 11 | 0.210 |
Why?
|
| Virus Attachment | 1 | 2021 | 3 | 0.200 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 13 | 0.200 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.200 |
Why?
|
| Dipeptides | 1 | 2021 | 22 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2021 | 103 | 0.180 |
Why?
|
| Drug Discovery | 1 | 2020 | 32 | 0.180 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 36 | 0.180 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 247 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 352 | 0.140 |
Why?
|
| Cdh1 Proteins | 1 | 2015 | 1 | 0.130 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2015 | 14 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2015 | 36 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2015 | 21 | 0.120 |
Why?
|
| Rhodium | 1 | 2014 | 3 | 0.120 |
Why?
|
| Platinum | 1 | 2014 | 17 | 0.120 |
Why?
|
| Proteolysis | 1 | 2014 | 55 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 95 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 184 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 245 | 0.100 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2011 | 5 | 0.090 |
Why?
|
| Hydrochloric Acid | 1 | 2011 | 14 | 0.090 |
Why?
|
| Catalytic Domain | 2 | 2023 | 77 | 0.080 |
Why?
|
| Cell Line | 2 | 2021 | 671 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 56 | 0.080 |
Why?
|
| Molecular Docking Simulation | 2 | 2021 | 46 | 0.080 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 17 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 651 | 0.070 |
Why?
|
| Animals | 5 | 2021 | 9918 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2015 | 206 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2015 | 155 | 0.060 |
Why?
|
| Sphingosine | 1 | 2023 | 22 | 0.060 |
Why?
|
| Cathepsin L | 1 | 2021 | 2 | 0.050 |
Why?
|
| Vero Cells | 1 | 2021 | 12 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2021 | 11 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 20 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 18 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2021 | 171 | 0.050 |
Why?
|
| Mice | 3 | 2015 | 4389 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 101 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2020 | 262 | 0.040 |
Why?
|
| Humans | 5 | 2021 | 26741 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 587 | 0.040 |
Why?
|
| Cerebellum | 1 | 2015 | 41 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 135 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 117 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 42 | 0.030 |
Why?
|
| Purines | 1 | 2013 | 14 | 0.030 |
Why?
|
| Half-Life | 1 | 2013 | 32 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2013 | 11 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 60 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 142 | 0.030 |
Why?
|
| Neurons | 1 | 2015 | 273 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2014 | 557 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 200 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 673 | 0.030 |
Why?
|
| Binding Sites | 1 | 2013 | 338 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1034 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2015 | 761 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 392 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 1535 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1254 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 1332 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 748 | 0.010 |
Why?
|